At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Adenosine A1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hyperlipidaemia; Pain; Reperfusion injury; Type 2 diabetes mellitus